I launched a Skool community.
Teaching you how to go from $0-$10K/month selling templates.
It’s going to cost $100/month in the future.
But for the next 48 hours only, it’s FREE to join.
To gain access, simply:
1. Like & Retweet
2. Reply "SKOOL"
3. Follow me (to receive DM)
I am thrilled to announce that my latest research article has been published: This study demonstrates for the first time that hMSCs transduced with lentiviral vectors can be successfully expanded in agitated conditions using microcarriers.
https://t.co/Vzi9XrsYPi
I am thrilled to announce that my latest research article has been published: This study demonstrates for the first time that hMSCs transduced with lentiviral vectors can be successfully expanded in agitated conditions using microcarriers.
https://t.co/Vzi9XrsYPi
(8/9) CAR-T Cost Analysis Evaluation - Study focused on evaluating the cost-effectiveness of CAR-T treatments as a second line of treatment for diffuse large B-cell lymphoma shows that it's a cost-effective option in the US but not in China.
https://t.co/aBsTRSnsfK
(7/9) Next Generation CAR Products - Study focused on designing a next-generation CAR-NK product to target triple-negative breast cancer (TNBC), demonstrated cytotoxicity in vitro using a 3D tumor model.
https://t.co/vzvdQKaxTk
(6/9) Bristol Myers Squibb (BMS) is expanding its manufacturing capabilities by taking over a Novartis plant in Libertyville, Illinois.
https://t.co/0UVME68jWx
(5/9) Janssen Biotech to pay $245M to Cellular Biomedicine Group (CBMG) to develop next-generation CAR-T therapies for diffuse large B-cell lymphoma (DLBCL).
https://t.co/BtvbfytC4G
(4/9) Ossium Health secures $3.46M funding from California Institute for Regenerative Medicine (CIRM) to accelerate the development of OSSM-007, a promising treatment for steroid-refractory acute graft versus host disease (GvHD).
https://t.co/00lxFmcGRr
(2/9) Direct Biologics receives FDA clearance for a clinical trial of ExoFlo™ in perianal fistulizing Crohn’s disease (news here). ExoFlo™ is an extracellular vesicle (EV) product using BM-hMSCs as a producer cell line (BM-hMSCs).
https://t.co/Ws4ofsEaEP